State Street’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$290M Sell
17,287,013
-34,312
-0.2% -$575K 0.01% 719
2025
Q1
$266M Sell
17,321,325
-2,092,722
-11% -$32.2M 0.01% 735
2024
Q4
$428M Sell
19,414,047
-86,636
-0.4% -$1.91M 0.02% 578
2024
Q3
$351M Buy
19,500,683
+1,778,268
+10% +$32M 0.01% 646
2024
Q2
$288M Buy
17,722,415
+1,499,143
+9% +$24.4M 0.01% 679
2024
Q1
$229M Sell
16,223,272
-142,754
-0.9% -$2.01M 0.01% 806
2023
Q4
$171M Buy
16,366,026
+360,683
+2% +$3.77M 0.01% 940
2023
Q3
$163M Buy
16,005,343
+431,999
+3% +$4.41M 0.01% 879
2023
Q2
$117M Sell
15,573,344
-3,991,484
-20% -$30.1M 0.01% 1108
2023
Q1
$173M Buy
19,564,828
+4,441,883
+29% +$39.3M 0.01% 848
2022
Q4
$138M Buy
15,122,945
+221,012
+1% +$2.02M 0.01% 960
2022
Q3
$120M Buy
14,901,933
+1,055,920
+8% +$8.52M 0.01% 1002
2022
Q2
$104M Sell
13,846,013
-1,744,479
-11% -$13.1M 0.01% 1123
2022
Q1
$146M Sell
15,590,492
-1,882,500
-11% -$17.7M 0.01% 1043
2021
Q4
$140M Sell
17,472,992
-60,575
-0.3% -$485K 0.01% 1046
2021
Q3
$171M Buy
17,533,567
+1,130,428
+7% +$11M 0.01% 924
2021
Q2
$162M Sell
16,403,139
-154,144
-0.9% -$1.53M 0.01% 966
2021
Q1
$191M Sell
16,557,283
-171,602
-1% -$1.98M 0.01% 821
2020
Q4
$161M Buy
16,728,885
+246,762
+1% +$2.38M 0.01% 838
2020
Q3
$149M Buy
16,482,123
+817,268
+5% +$7.36M 0.01% 788
2020
Q2
$193M Buy
15,664,855
+261,870
+2% +$3.23M 0.01% 668
2020
Q1
$138M Buy
15,402,985
+2,863,465
+23% +$25.7M 0.01% 722
2019
Q4
$123M Buy
12,539,520
+638,141
+5% +$6.25M 0.01% 916
2019
Q3
$81.9M Sell
11,901,379
-681,800
-5% -$4.69M 0.01% 1125
2019
Q2
$116M Buy
12,583,179
+1,960,758
+18% +$18.1M 0.01% 935
2019
Q1
$167M Buy
10,622,421
+886,511
+9% +$13.9M 0.01% 738
2018
Q4
$150M Buy
9,735,910
+175,784
+2% +$2.71M 0.01% 710
2018
Q3
$206M Buy
9,560,126
+1,545,420
+19% +$33.3M 0.02% 700
2018
Q2
$195M Buy
8,014,706
+418,408
+6% +$10.2M 0.02% 700
2018
Q1
$130M Sell
7,596,298
-1,282,545
-14% -$21.9M 0.01% 857
2017
Q4
$168M Buy
8,878,843
+1,851,036
+26% +$35.1M 0.01% 753
2017
Q3
$124M Buy
7,027,807
+2,264,115
+48% +$39.8M 0.01% 867
2017
Q2
$158M Buy
4,763,692
+232,924
+5% +$7.74M 0.01% 737
2017
Q1
$145M Buy
4,530,768
+621,795
+16% +$20M 0.01% 771
2016
Q4
$142M Buy
3,908,973
+3,231,791
+477% +$117M 0.01% 743
2016
Q3
$31.2M Buy
677,182
+55,006
+9% +$2.53M ﹤0.01% 1481
2016
Q2
$31.3M Sell
622,176
-127,438
-17% -$6.4M ﹤0.01% 1434
2016
Q1
$40.1M Sell
749,614
-169,848
-18% -$9.09M ﹤0.01% 1263
2015
Q4
$60.4M Buy
919,462
+155,135
+20% +$10.2M 0.01% 1074
2015
Q3
$43.2M Sell
764,327
-248,634
-25% -$14M 0.01% 1258
2015
Q2
$60M Sell
1,012,961
-85,210
-8% -$5.04M 0.01% 1154
2015
Q1
$68.4M Buy
1,098,171
+43,024
+4% +$2.68M 0.01% 1065
2014
Q4
$60.7M Sell
1,055,147
-140,752
-12% -$8.09M 0.01% 1122
2014
Q3
$64.3M Buy
1,195,899
+20,300
+2% +$1.09M 0.01% 1044
2014
Q2
$61.6M Sell
1,175,599
-1,606
-0.1% -$84.2K 0.01% 1119
2014
Q1
$62.2M Sell
1,177,205
-16,351
-1% -$864K 0.01% 1083
2013
Q4
$47.8M Buy
1,193,556
+166,129
+16% +$6.66M 0.01% 1217
2013
Q3
$38.8M Buy
1,027,427
+220,176
+27% +$8.32M ﹤0.01% 1301
2013
Q2
$31.6M Buy
+807,251
New +$31.6M ﹤0.01% 1351